Biotech Values

[DewDiligence]

I can't find explicit language in the contract that requires Momenta to reimburse the development costs Sandoz picked up over the years.

I’m pretty sure the (redacted) provision of the NVS-MNTA agreement pertaining to reimbursement of NVS’ development costs is in the SEC filing I cited, but it’s now moot insofar as the disclosure in #msg-52868377 tells us everything we need to know.